Conference
Quality of life (QoL) benefits following 177Lu-DOTATATE therapy in patients (pts) with 68Ga-DOTATATE PET positive primary site agnostic neuroendocrine tumors (NET)
Authors
Wong RKS; Myrehaug S; Juergens RA; Laidley D; Ezzat S; Beauregard J-M; Levine OH; Veit-Haibach P; Metser U; Driscoll B
Volume
42
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 1, 2024
Name of conference
Special Clinical Science Symposia
Conference place
ELECTR NETWORK
Conference start date
May 29, 2024
Conference end date
May 29, 2024
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X